STOCK TITAN

Praxis Precision Medicines to Present at Citi’s 16th Annual BioPharma Virtual Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Praxis Precision Medicines (NASDAQ: PRAX) will participate in the ‘Emerging Therapies for Psychiatric Disorders’ panel at Citi’s 16th Annual BioPharma Virtual Conference on September 8, 2021, at 10:40 a.m. ET. The event will focus on translating genetic insights into therapies for CNS disorders. Interested individuals can access the live webcast on the company’s website, with a replay available for 90 days post-event. Praxis is advancing multiple clinical-stage product candidates targeting epilepsy, depression, and more.

Positive
  • None.
Negative
  • None.

CAMBRIDGE, Mass., Sept. 01, 2021 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal imbalance, today announced that management will participate in the ‘Emerging Therapies for Psychiatric Disorders’ panel at Citi’s 16th Annual BioPharma Virtual Conference on Wednesday, September 8, 2021 at 10:40 a.m. ET.

The panel will be available via live webcast through the Events & Presentations page of the Investors + Media section of the company’s website at www.praxismedicines.com. A replay of the webcast will be available on Praxis’ website for 90 days following the event.

About Praxis
Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system disorders (CNS) characterized by neuronal imbalance. Praxis is applying insights from genetic epilepsies to broader neurological and psychiatric disorders, using our understanding of shared biological targets and circuits in the brain. Praxis has established a broad portfolio, including multiple disclosed programs across CNS disorders including depression, epilepsy, movement disorders and pain syndromes, with three clinical-stage product candidates. For more information, please visit www.praxismedicines.com and follow us on LinkedIn and Twitter.


FAQ

What is the date of the panel discussion by Praxis Precision Medicines at the Citi BioPharma Conference?

The panel discussion will take place on September 8, 2021.

At what time will Praxis participate in the Citi’s BioPharma Virtual Conference?

Praxis will participate in the panel at 10:40 a.m. ET.

How can I watch the panel discussion featuring Praxis Precision Medicines?

The panel will be available via live webcast on the company’s website.

What topics will Praxis discuss at the Citi BioPharma Conference?

Praxis will focus on emerging therapies for psychiatric disorders and CNS disorders.

Is there a replay available for the Praxis presentation at the virtual conference?

Yes, a replay will be available on Praxis’ website for 90 days after the event.

Praxis Precision Medicines, Inc.

NASDAQ:PRAX

PRAX Rankings

PRAX Latest News

PRAX Stock Data

1.37B
17.35M
0.25%
103.96%
8.2%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
BOSTON